Drospirenone-only pill for Emergency Contraception

"Due to its Phase 2 designation, our team has assigned Dose Finding a safety score of 2, indicating that there is some data available supporting the medication's security but no clinical proof for efficacy."

"This clinical trial is offering 35 slots to participants aged 18-35 who are taking birth control. Some of the key eligibility requirements include having a body mass index (BMI) less than 30 kg/m2, possessing an intact uterus with at least 1 ovary, passing a negative urine pregnancy test both during screening and when drospirenone is administered, using barrier contraception or other non-hormonal methods throughout the study period, confirming ovulation via progesterone level testing that should be higher than 3ng/ml during screening visits, being in good general health overall, and meeting age criteria."

"This clinical trial is only open to candidates between the ages of 18 and 35. For younger patients, there are 59 studies available whereas those over 65 have 171 options at their disposal."

"Contradictorily, the information hosted on clinicaltrials.gov indicates that this medical trial is not accepting recruits. Initially posted in February of 2023 and last updated in December 2022, it appears to have reached its recruitment goals as there are now 241 other trials actively looking for participants."